202 related articles for article (PubMed ID: 9348302)
21. Failure of CD25+ T cells from lupus-prone mice to suppress lupus glomerulonephritis and sialoadenitis.
Bagavant H; Tung KS
J Immunol; 2005 Jul; 175(2):944-50. PubMed ID: 16002693
[TBL] [Abstract][Full Text] [Related]
22. CXCR3 promotes the production of IgG1 autoantibodies but is not essential for the development of lupus nephritis in NZB/NZW mice.
Moser K; Kalies K; Szyska M; Humrich JY; Amann K; Manz RA
Arthritis Rheum; 2012 Apr; 64(4):1237-46. PubMed ID: 22006377
[TBL] [Abstract][Full Text] [Related]
23. High titer anti-basement membrane antibodies in a subset of patients with pediatric systemic lupus erythematosus.
Orjuela A; Suwanichkul A; Canter D; Minard CG; Devaraj S; Hicks MJ; Muscal E; Wenderfer SE
Am J Nephrol; 2015; 41(3):241-7. PubMed ID: 25926050
[TBL] [Abstract][Full Text] [Related]
24. Nucleosome-restricted antibodies are detected before anti-dsDNA and/or antihistone antibodies in serum of MRL-Mp lpr/lpr and +/+ mice, and are present in kidney eluates of lupus mice with proteinuria.
Amoura Z; Chabre H; Koutouzov S; Lotton C; Cabrespines A; Bach JF; Jacob L
Arthritis Rheum; 1994 Nov; 37(11):1684-8. PubMed ID: 7980678
[TBL] [Abstract][Full Text] [Related]
25. Treatment with dsDNA-anti-dsDNA antibody complexes extends survival, decreases anti-dsDNA antibody production and reduces severity of nephritis in MRLlpr mice.
Burny W; Lebrun P; Cosyns JP; Saint-Remy JM
Lupus; 1997; 6(1):4-17. PubMed ID: 9116717
[TBL] [Abstract][Full Text] [Related]
26. Expression of natural autoantibodies in MRL-lpr mice protects from lupus nephritis and improves survival.
Mannoor K; Matejuk A; Xu Y; Beardall M; Chen C
J Immunol; 2012 Apr; 188(8):3628-38. PubMed ID: 22407922
[TBL] [Abstract][Full Text] [Related]
27. Amelioration of lupus nephritis by serum amyloid P component gene therapy with distinct mechanisms varied from different stage of the disease.
Zhang W; Wu J; Qiao B; Xu W; Xiong S
PLoS One; 2011; 6(7):e22659. PubMed ID: 21799927
[TBL] [Abstract][Full Text] [Related]
28. Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice.
Anders HJ; Vielhauer V; Eis V; Linde Y; Kretzler M; Perez de Lema G; Strutz F; Bauer S; Rutz M; Wagner H; Gröne HJ; Schlöndorff D
FASEB J; 2004 Mar; 18(3):534-6. PubMed ID: 14734643
[TBL] [Abstract][Full Text] [Related]
29. IL-3 contributes to development of lupus nephritis in MRL/lpr mice.
Renner K; Hermann FJ; Schmidbauer K; Talke Y; Rodriguez Gomez M; Schiechl G; Schlossmann J; Brühl H; Anders HJ; Mack M
Kidney Int; 2015 Nov; 88(5):1088-98. PubMed ID: 26131743
[TBL] [Abstract][Full Text] [Related]
30. Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane.
Satoh M; Kumar A; Kanwar YS; Reeves WH
Proc Natl Acad Sci U S A; 1995 Nov; 92(24):10934-8. PubMed ID: 7479913
[TBL] [Abstract][Full Text] [Related]
31. IFN-gamma is essential for the development of autoimmune glomerulonephritis in MRL/Ipr mice.
Haas C; Ryffel B; Le Hir M
J Immunol; 1997 Jun; 158(11):5484-91. PubMed ID: 9164971
[TBL] [Abstract][Full Text] [Related]
32. Chemically modified ribozyme to V gene inhibits anti-DNA production and the formation of immune deposits caused by lupus lymphocytes.
Suzuki Y; Funato T; Munakata Y; Sato K; Hirabayashi Y; Ishii T; Takasawa N; Ootaka T; Saito T; Sasaki T
J Immunol; 2000 Nov; 165(10):5900-5. PubMed ID: 11067951
[TBL] [Abstract][Full Text] [Related]
33. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
Wang H; Li T; Chen S; Gu Y; Ye S
Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
[TBL] [Abstract][Full Text] [Related]
34. Essential Requirement for IFN Regulatory Factor 7 in Autoantibody Production but Not Development of Nephritis in Murine Lupus.
Miyagawa F; Tagaya Y; Ozato K; Asada H
J Immunol; 2016 Sep; 197(6):2167-76. PubMed ID: 27527596
[TBL] [Abstract][Full Text] [Related]
35. Suppression of lupus nephritis and skin lesions in MRL/lpr mice by administration of the topoisomerase I inhibitor irinotecan.
Keil A; Hall SR; Körner M; Herrmann M; Schmid RA; Frese S
Arthritis Res Ther; 2016 Oct; 18(1):243. PubMed ID: 27770825
[TBL] [Abstract][Full Text] [Related]
36. Chemical induction of HO-1 suppresses lupus nephritis by reducing local iNOS expression and synthesis of anti-dsDNA antibody.
Takeda Y; Takeno M; Iwasaki M; Kobayashi H; Kirino Y; Ueda A; Nagahama K; Aoki I; Ishigatsubo Y
Clin Exp Immunol; 2004 Nov; 138(2):237-44. PubMed ID: 15498032
[TBL] [Abstract][Full Text] [Related]
37. IL-18 cDNA vaccination protects mice from spontaneous lupus-like autoimmune disease.
Bossù P; Neumann D; Del Giudice E; Ciaramella A; Gloaguen I; Fantuzzi G; Dinarello CA; Di Carlo E; Musiani P; Meroni PL; Caselli G; Ruggiero P; Boraschi D
Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14181-6. PubMed ID: 14615579
[TBL] [Abstract][Full Text] [Related]
38. Differential effect of the autoimmune Yaa and lpr genes on the acceleration of lupus-like syndrome in MRL/MpJ mice.
Merino R; Shibata T; De Kossodo S; Izui S
Eur J Immunol; 1989 Nov; 19(11):2131-7. PubMed ID: 2599002
[TBL] [Abstract][Full Text] [Related]
39. Induction of a cationic shift in IgG anti-DNA autoantibodies. Role of T helper cells with classical and novel phenotypes in three murine models of lupus nephritis.
Datta SK; Patel H; Berry D
J Exp Med; 1987 May; 165(5):1252-68. PubMed ID: 2952749
[TBL] [Abstract][Full Text] [Related]
40. Circulating levels of chromatin fragments are inversely correlated with anti-dsDNA antibody levels in human and murine systemic lupus erythematosus.
Jørgensen MH; Rekvig OP; Jacobsen RS; Jacobsen S; Fenton KA
Immunol Lett; 2011 Aug; 138(2):179-86. PubMed ID: 21530588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
